TFF Pharmaceuticals Inc.

10/28/2021 | Press release | Distributed by Public on 10/28/2021 07:22

TFF Pharmaceuticals Receives Approval from Health Canada to Enter Human Clinical Trials for Inhaled Formulation of Niclosamide to Treat COVID-19